U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C13H16N2O
Molecular Weight 216.2789
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EFAROXAN

SMILES

CCC1(CC2=C(O1)C=CC=C2)C3=NCCN3

InChI

InChIKey=RATZLMXRALDSJW-UHFFFAOYSA-N
InChI=1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15)

HIDE SMILES / InChI
Molecular Formula C13H16N2O
Molecular Weight 216.2789
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:32:37 UTC 2023
Edited
by admin
on Sat Dec 16 16:32:37 UTC 2023
Record UNII
G00490L21H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EFAROXAN
INN  
INN  
Official Name English
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-4,5-DIHYDRO-1H-IMIDAZOLE
Systematic Name English
NSC-759562
Code English
1H-IMIDAZOLE, 2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-4,5-DIHYDRO-
Systematic Name English
efaroxan [INN]
Common Name English
(±)-2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-2-IMIDAZOLINE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29713
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID8045149
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
MESH
C062597
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
SMS_ID
100000080533
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
NCI_THESAURUS
C72923
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
CAS
89197-32-0
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
INN
6216
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
WIKIPEDIA
EFAROXAN
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
ChEMBL
CHEMBL57895
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
EVMPD
SUB06462MIG
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
FDA UNII
G00490L21H
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
NSC
759562
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
PUBCHEM
72016
Created by admin on Sat Dec 16 16:32:38 UTC 2023 , Edited by admin on Sat Dec 16 16:32:38 UTC 2023
PRIMARY
Related Record Type Details
ALPHA-2A ADRENERGIC RECEPTOR
TARGET -> AGONIST
SHORT-ACTING
Nischarin
TARGET -> INHIBITOR
Ki
Structure of EFAROXAN, (S)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of EFAROXAN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966